Upper respiratory tract infection: FDA reporting patterns
45,543 FDA FAERS reports mention Upper respiratory tract infection. 26,674 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 4,900 reports
- Adalimumab: 4,878 reports
- Rituximab: 1,967 reports
- Tofacitinib: 1,948 reports
- Methotrexate: 1,809 reports
- Abatacept: 1,800 reports
- Lenalidomide: 1,626 reports
- Human Immunoglobulin G: 1,619 reports
- Tocilizumab: 1,608 reports
- Prednisone: 1,564 reports
- Infliximab: 1,555 reports
- Apremilast: 1,504 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.